Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Cognition and ACHE[original query] |
---|
A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenetics and genomics 2006 Feb 16 (2): 75-7. Harold Denise, Macgregor Stuart, Patterson Cathryn E, Hollingworth Paul, Moore Pamela, Owen Michael J, Williams Julie, O'Donovan Michael, Passmore Peter, McIlroy Stephen, Jones Lesl |
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies. Current Alzheimer research 2011 Aug 8 (5): 592-606. Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders A M, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck C H, Gold |
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels. Frontiers in pharmacology 2020 11 691. Ortner Marion, Stange Marion, Schneider Heike, Schroeder Charlotte, Buerger Katharina, Müller Claudia, Dorn Bianca, Goldhardt Oliver, Diehl-Schmid Janine, Förstl Hans, Steimer Werner, Grimmer Ti |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 05, 2023
- Content source: